Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Osteosarcoma × Zoledronic Acid × Clear all

Phase

Phase 1 4 Phase 3 1 Phase 2/3 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 2 Osteosarcoma 1 Metastatic Breast Cancer With Bone Involvement 1 Insulin Resistance 1 Breast Neoplasms 1

Interventions

Doxorubicin 2 apatinib 1 Zoledronic Acid 1 Triptorelin Pamoate 1 Methotrexate 1 Ifosfamide 1 Drug Therapy 1 Cisplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00691236 2011-06-23

ZOL

Tata Memorial Hospital

Phase 2/3 Unknown

Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡